Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | |
---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||||
Cash from operating activities | -4.48%841.78M | 80.74%881.22M | -78.20%487.55M | 283.67%2.24B | 1,533.72%582.89M | 112.20%35.68M | -292.5M |
Net profit before non-cash adjustment | 228.97%523.36M | -171.97%-405.81M | -75.89%563.89M | 471.93%2.34B | 323.60%409M | 46.24%-182.91M | ---340.24M |
Total adjustment of non-cash items | -59.43%489.02M | 632.67%1.21B | 41.22%164.51M | 104.92%116.49M | 199.56%56.85M | -57.05%18.98M | --44.18M |
-Depreciation and amortization | 8.18%489.16M | 236.35%452.18M | 91.81%134.44M | 112.30%70.09M | 85.18%33.01M | 16.19%17.83M | --15.34M |
-Disposal profit | -113.92%-95.39M | --685.29M | --0 | --26.46M | ---- | --0 | --0 |
-Net exchange gains and losses | ---- | ---- | ---- | ---- | ---- | -37.50%45K | --72K |
-Remuneration paid in stock | 46.04%85.2M | 83.77%58.34M | 16.23%31.75M | --27.31M | ---- | ---- | ---- |
-Other non-cash items | 5.72%10.05M | 668.02%9.5M | 77.32%-1.67M | -130.95%-7.38M | 2,060.65%23.83M | -96.17%1.1M | --28.76M |
Changes in working capital | -308.76%-170.6M | 133.93%81.72M | -9.83%-240.85M | -287.35%-219.3M | -41.36%117.05M | 5,505.64%199.62M | --3.56M |
-Change in receivables | 91.30%-9.27M | -134.40%-106.5M | 144.50%309.59M | -854.07%-695.69M | -141.11%-72.92M | 477.28%177.37M | ---47.01M |
-Change in inventory | ---- | ---- | ---- | 203.59%1.59M | -2,685.45%-1.53M | ---55K | ---- |
-Change in payables | -179.08%-101.04M | 150.60%127.77M | -256.95%-252.52M | 98.52%160.89M | --81.05M | ---- | ---- |
-Provision for loans, leases and other losses | 48.74%51.82M | 118.86%34.84M | -173.45%-184.72M | 412,380.33%251.49M | -128.37%-61K | -15.02%215K | --253K |
-Changes in other current assets | -1,532.13%-142.34M | 113.50%9.94M | -123.03%-73.65M | -624.96%-33.02M | -159.16%-4.56M | 470.91%7.7M | ---2.08M |
-Changes in other current liabilities | 92.90%30.24M | 139.63%15.68M | -141.44%-39.55M | -17.05%95.45M | 699.86%115.07M | -72.54%14.39M | --52.4M |
Dividends paid (cash flow from operating activities) | |||||||
Dividends received (cash flow from operating activities) | |||||||
Interest paid (cash flow from operating activities) | 5.71%-9.49M | -1.99%-10.06M | -208.28%-9.87M | -114.11%-3.2M | -22.54%-1.5M | -1.22M | |
Interest received (cash flow from operating activities) | 45.00%29K | -99.83%20K | 8.39%11.54M | 118,233.33%10.65M | 125.00%9K | 100.00%4K | 2K |
Tax refund paid | -22.25%-94.54M | 88.92%-77.33M | -353.96%-698.06M | -16,086.63%-153.77M | -227.59%-950K | 0.00%-290K | -290K |
Other operating cash inflow (outflow) | 0.00%-1K | 0.00%-1K | 0.00%-1K | -200.00%-1K | 200.00%1K | 100.00%-1K | -28.76M |
Operating cash flow | -7.06%737.78M | 480.14%793.85M | -109.99%-208.83M | 260.07%2.09B | 1,598.64%580.46M | 110.63%34.17M | ---321.55M |
Investing cash flow | |||||||
Net PPE purchase and sale | 89.62%-14.51M | -24.63%-139.75M | 21.38%-112.13M | -82.65%-142.62M | -537.10%-78.08M | 62.38%-12.26M | ---32.58M |
Net intangibles purchase and sale | --0 | -159.63%-289.5M | -19.44%-111.51M | ---93.36M | ---- | ---- | ---- |
Net business purchase and sale | 134.16%560.84M | ---1.64B | --0 | ---1.24B | ---- | ---- | ---- |
Net investment product transactions | --50.31M | --0 | ---- | ---29.99M | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | --72K | ---- | --163K |
Net changes in other investments | -61.89%897K | --2.35M | ---- | 99.99%-2K | ---25.67M | ---- | ---22.29M |
Investing cash flow | 128.88%597.53M | -825.12%-2.07B | 85.13%-223.64M | -1,350.47%-1.5B | -745.94%-103.68M | 77.59%-12.26M | ---54.7M |
Financing cash flow | |||||||
Net issuance payments of debt | 97.72%-990K | ---43.4M | --0 | --1.5B | --0 | --100M | ---- |
Net common stock issuance | -96.83%690K | -38.32%21.75M | -82.02%35.26M | -84.41%196.13M | 164.78%1.26B | -1.00%475.2M | --480M |
Net other fund-raising expenses | ---- | ---- | 0.00%-1K | ---1K | ---- | ---- | ---- |
Financing cash flow | 98.61%-300K | -161.41%-21.65M | -97.92%35.26M | 34.80%1.7B | 118.75%1.26B | 19.83%575.2M | --480M |
Net cash flow | |||||||
Beginning cash position | -26.80%3.24B | -8.25%4.42B | 90.07%4.82B | 217.13%2.53B | 295.58%799.07M | 105.44%202M | --98.33M |
Current changes in cash | 202.95%1.34B | -226.45%-1.3B | -117.40%-397.21M | 31.55%2.28B | 190.57%1.74B | 475.55%597.12M | --103.75M |
Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | 37.50%-45K | ---72K |
Cash adjustments other than cash changes | ---- | --112.5M | ---- | ---- | ---1K | ---- | ---2K |
End cash Position | 41.27%4.57B | -26.80%3.24B | -8.25%4.42B | 90.07%4.82B | 217.13%2.53B | 295.58%799.07M | --202M |
Free cash flow | 98.38%723.28M | 184.31%364.6M | -123.32%-432.47M | 269.07%1.85B | 2,192.28%502.38M | 106.19%21.92M | ---354.13M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |